{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T12:04:55Z","timestamp":1784462695006,"version":"3.55.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,19]]},"DOI":"10.7759\/cureus.112942","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T11:40:14Z","timestamp":1784461214000},"source":"Crossref","is-referenced-by-count":0,"title":["Vitiligo Masked by Steroid-Induced Rosacea-Like Dermatitis and Revealed by VISIA Ultraviolet Imaging: A Longitudinal Case Report"],"prefix":"10.7759","author":[{"given":"Yasir","family":"Radhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Almamoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14443","article-title":"Topical steroid-induced perioral dermatitis (TOP STRIPED): case report of a man who developed topical steroid-induced rosacea-like dermatitis (TOP SIDE RED)","volume":"13","author":"Diehl KL","year":"2021","unstructured":"Diehl KL, Cohen PR. Topical steroid-induced perioral dermatitis (TOP STRIPED): case report of a man who developed topical steroid-induced rosacea-like dermatitis (TOP SIDE RED). Cureus. 2021, 13:e14443. 10.7759\/cureus.14443","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.74974","article-title":"Topical corticosteroid-induced rosacea-like dermatitis: a clinical study of 110 cases","volume":"77","author":"Rathi SK","year":"2011","unstructured":"Rathi SK, Kumrah L. Topical corticosteroid-induced rosacea-like dermatitis: a clinical study of 110 cases. Indian J Dermatol Venereol Leprol. 2011, 77:42-46. 10.4103\/0378-6323.74974","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist C","year":"2020","unstructured":"Bergqvist C, Ezzedine K. Vitiligo: a review. Dermatology. 2020, 236:571-592. 10.1159\/000506103","journal-title":"Dermatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13509","article-title":"Evaluation of skin ageing: a systematic review of clinical scales","volume":"172","author":"Dobos G","year":"2015","unstructured":"Dobos G, Lichterfeld A, Blume-Peytavi U, Kottner J. Evaluation of skin ageing: a systematic review of clinical scales. Br J Dermatol. 2015, 172:1249-1261. 10.1111\/bjd.13509","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3205\/iprs000169","article-title":"Investigation of the precision of the Visia(\u00ae) complexion analysis camera system in the assessment of skin surface features","volume":"11","author":"Henseler H","year":"2022","unstructured":"Henseler H. Investigation of the precision of the Visia(\u00ae) complexion analysis camera system in the assessment of skin surface features. GMS Interdiscip Plast Reconstr Surg DGPW. 2022, 11:Doc08. 10.3205\/iprs000169","journal-title":"GMS Interdiscip Plast Reconstr Surg DGPW"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1200963","article-title":"Non-invasive skin measurement methods and diagnostics for vitiligo: a systematic review","volume":"10","author":"Abdi P","year":"2023","unstructured":"Abdi P, Anthony MR, Farkouh C, Chan AR, Kooner A, Qureshi S, Maibach H. Non-invasive skin measurement methods and diagnostics for vitiligo: a systematic review. Front Med (Lausanne). 2023, 10:1200963. 10.3389\/fmed.2023.1200963","journal-title":"Front Med (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2011.00838.x","article-title":"Koebner's phenomenon in vitiligo: European position paper","volume":"24","author":"van Geel N","year":"2011","unstructured":"van Geel N, Speeckaert R, Taieb A, et al.. Koebner's phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res. 2011, 24:564-573. 10.1111\/j.1755-148X.2011.00838.x","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.190070","article-title":"Koebner phenomenon in vitiligo after suction blister epidermal grafting","volume":"191","author":"Liu W","year":"2019","unstructured":"Liu W, Ma DL. Koebner phenomenon in vitiligo after suction blister epidermal grafting. CMAJ. 2019, 191:E968. 10.1503\/cmaj.190070","journal-title":"CMAJ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13249","article-title":"Novel ultraviolet-dermoscopy: early diagnosis and activity evaluation of vitiligo","volume":"29","author":"Yuan M","year":"2023","unstructured":"Yuan M, Xie Y, Zheng Y, Zhang Z, Yang C, Li J. Novel ultraviolet-dermoscopy: early diagnosis and activity evaluation of vitiligo. Skin Res Technol. 2023, 29:e13249. 10.1111\/srt.13249","journal-title":"Skin Res Technol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.0696","article-title":"Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo: a systematic review and meta-analysis","volume":"155","author":"Lee JH","year":"2019","unstructured":"Lee JH, Kwon HS, Jung HM, Lee H, Kim GM, Yim HW, Bae JM. Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo: a systematic review and meta-analysis. JAMA Dermatol. 2019, 155:929-938. 10.1001\/jamadermatol.2019.0696","journal-title":"JAMA Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.12.028","article-title":"Efficacy and safety of tacrolimus 0.1% for the treatment of facial vitiligo: a multicenter randomized, double-blinded, vehicle-controlled study","volume":"141","author":"Seneschal J","year":"2021","unstructured":"Seneschal J, Duplaine A, Maillard H, et al.. Efficacy and safety of tacrolimus 0.1% for the treatment of facial vitiligo: a multicenter randomized, double-blinded, vehicle-controlled study. J Invest Dermatol. 2021, 141:1728-1734. 10.1016\/j.jid.2020.12.028","journal-title":"J Invest Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/508142-vitiligo-masked-by-steroid-induced-rosacea-like-dermatitis-and-revealed-by-visia-ultraviolet-imaging-a-longitudinal-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T11:40:15Z","timestamp":1784461215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/508142-vitiligo-masked-by-steroid-induced-rosacea-like-dermatitis-and-revealed-by-visia-ultraviolet-imaging-a-longitudinal-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.112942","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,19]]}}}